Myriad genetics: Patent law and genetic testing
| Data(s) |
2003
|
|---|---|
| Resumo |
This paper considers the legal challenges to the legal validity of the patents held by Myriad Genetics in respect of genetic testing for breast cancer and ovarian cancer. It argues that broad-based patents on gene sequences and medical diagnostics will have a harmful effect upon access to patient care, genetic research, and the administration of public health care. |
| Identificador | |
| Publicador |
Thomson/Sweet and Maxwell |
| Relação |
http://www.sweetandmaxwell.co.uk/catalogue/productdetails.aspx?productid=7061&recordid=460 Rimmer, Matthew (2003) Myriad genetics: Patent law and genetic testing. European Intellectual Property Review, 25(1), pp. 20-33. |
| Fonte |
Faculty of Law; School of Law |
| Palavras-Chave | #Patent law #novelty inventive #compulsory licensing #ethical objections #research exemption #genetic testing #inventorship #European Biotechnology Directive #step utility #Intellectual Property and Innovation Law Research Group |
| Tipo |
Journal Article |
